Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations H Abdelkader, AWG Alani, RG Alany Drug delivery 21 (2), 87-100, 2014 | 349 | 2014 |
Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery H Abdelkader, S Ismail, A Kamal, RG Alany Journal of pharmaceutical sciences 100 (5), 1833-1846, 2011 | 202 | 2011 |
Corticosteroids in ophthalmology: Drug delivery innovations, pharmacology, clinical applications, and future perspectives SA Gaballa, UB Kompella, O Elgarhy, AM Alqahtani, B Pierscionek, ... Drug Delivery and Translational Research 11, 866-893, 2021 | 190 | 2021 |
New therapeutic approaches in the treatment of diabetic keratopathy: a review H Abdelkader, DV Patel, CNJ McGhee, RG Alany Clinical & experimental ophthalmology 39 (3), 259-270, 2011 | 122 | 2011 |
Cubosomes: composition, preparation, and drug delivery applications. SA Gaballa, OH El Garhy, H Abdelkader Journal of advanced biomedical and pharmaceutical sciences 3 (1), 1-9, 2020 | 109 | 2020 |
Formulation of controlled-release baclofen matrix tablets: Influence of some hydrophilic polymers on the release rate and in vitro evaluation H Abdelkader, OY Abdalla, H Salem Aaps pharmscitech 8, 156-166, 2007 | 109 | 2007 |
Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models H Abdelkader, S Ismail, A Hussein, Z Wu, R Al-Kassas, RG Alany International journal of pharmaceutics 432 (1-2), 1-10, 2012 | 105 | 2012 |
Age-related cataract and drug therapy: opportunities and challenges for topical antioxidant delivery to the lens H Abdelkader, RG Alany, B Pierscionek Journal of Pharmacy and Pharmacology 67 (4), 537-550, 2015 | 101 | 2015 |
Preparation, characterization and evaluation of novel elastic nano-sized niosomes (ethoniosomes) for ocular delivery of prednisolone PME Gaafar, OY Abdallah, RM Farid, H Abdelkader Journal of liposome research 24 (3), 204-215, 2014 | 100 | 2014 |
Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects H Abdelkader, Z Wu, R Al-Kassas, RG Alany International journal of pharmaceutics 433 (1-2), 142-148, 2012 | 99 | 2012 |
Controlled and continuous release ocular drug delivery systems: pros and cons H Abdelkader, R G Alany Current drug delivery 9 (4), 421-430, 2012 | 96 | 2012 |
Phytosome-hyaluronic acid systems for ocular delivery of L-carnosine H Abdelkader, MR Longman, RG Alany, B Pierscionek International journal of nanomedicine, 2815-2827, 2016 | 89 | 2016 |
Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: Inserts, patches, wafers, and implants H Abdelkader, Z Fathalla, A Seyfoddin, M Farahani, T Thrimawithana, ... Advanced drug delivery reviews 177, 113957, 2021 | 87 | 2021 |
Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization H Abdelkader, S Ismail, A Kamal, RG Alany Die Pharmazie-An International Journal of Pharmaceutical Sciences 65 (11 …, 2010 | 79 | 2010 |
Formulation and clinical evaluation of silymarin pluronic-lecithin organogels for treatment of atopic dermatitis FM Mady, H Essa, T El-Ammawi, H Abdelkader, AK Hussein Drug design, development and therapy, 1101-1110, 2016 | 75 | 2016 |
Formulation of Controlled-Release Baclofen Matrix Tablets II: Influence of Some Hydrophobic Excipients on the Release Rate and In Vitro Evaluation H Abdelkader, O Youssef Abdalla, H Salem Aaps Pharmscitech 9, 675-683, 2008 | 71 | 2008 |
Cyclodextrin enhances corneal tolerability and reduces ocular toxicity caused by diclofenac H Abdelkader, Z Fathalla, H Moharram, TFS Ali, B Pierscionek Oxidative medicine and cellular longevity 2018 (1), 5260976, 2018 | 64 | 2018 |
The suprachoroidal pathway: a new drug delivery route to the back of the eye UDJP Rai, SA Young, TR Thrimawithana, H Abdelkader, AWG Alani, ... Drug discovery today 20 (4), 491-495, 2015 | 63 | 2015 |
Novel in situ gelling ocular films for the opioid growth factor-receptor antagonist-naltrexone hydrochloride: Fabrication, mechanical properties, mucoadhesion, tolerability and … H Abdelkader, B Pierscionek, RG Alany International journal of pharmaceutics 477 (1-2), 631-642, 2014 | 53 | 2014 |
Critical appraisal of alternative irritation models: three decades of testing ophthalmic pharmaceuticals H Abdelkader, B Pierscionek, M Carew, Z Wu, RG Alany British medical bulletin 113 (1), 59-71, 2015 | 52 | 2015 |